Balyasny Asset Management »

Exagen shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Exagen (XGN) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.0M 723k 10.99
2025-06-30 $5.0M 719k 6.98

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Exagen

Rtw Investments
Vanguard Group
Balyasny Asset Management
Invesco
Kennedy Capital Management
Morgan Stanley
Silvercrest Asset Management Group
Wexford Capital
Millennium Management
Two Sigma Investments
Russell Investments
FourWorld Capital Management
Susquehanna International
Manatuck Hill Partners
Geode Capital Management

View all funds holding Exagen